Rumors Around Humana Interested In Buying Centene
Rumors are swirling, again, that Humana Inc (NYSE: HUM) is interested in buying Medicaid managed-care company Centene Corp (NYSE: CNC).
‘Humana said to be interested in buying Centene’ -Street Insider
https://newsfilter.io/articles/humana-said-to-be-interested-in-buying-centene---street-insider-4d65f45abf4ed9d73599b5dfdf4a8945
Barclays Reinstates Overweight on Humana, Announces $500 Price Target
Barclays analyst Steve Valiquette reinstates Humana (NYSE:HUM) with a Overweight and announces $500 price target.
Morgan Stanley Maintains Overweight on Humana, Raises Price Target to $513
Morgan Stanley analyst Craig Hettenbach maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $500 to $513.
Seaport Global Initiates Coverage On Humana with Neutral Rating
Seaport Global analyst Joseph France initiates coverage on Humana (NYSE:HUM) with a Neutral rating.
Biogen’s Costly Alzheimer’s Treatment May Face Restricted Medicare Access: WSJ
The recent approval of Biogen Inc’s (NASDAQ:BIIB) high-price Alzheimer’s drug is raising questions about who will have access to the $56,000/year treatment…
Humana Reports Partnership With League To Digitally Transform Healthcare Experience, No Terms Disclosed
Collaboration will enable a personalized, simplified and connected “digital front door” for Humana Employer Group and Specialty members
CHICAGO & LOUISVILLE, Ky.--(BUSINESS WIRE)-- League, a
Shares Of Pharmacy/Healthcare Stocks Quiet As Traders Circulate Statement From FTC Commissioner Dated Friday That Criticizes Pharmacy Benefits Manager Industry, Is Calling For FTC, Congress To Take Steps To Address Issues In Industry
https://www.ftc.gov/system/files/documents/public_statements/1590528/statement_of_commissioner_rohit_chopra_regarding_the_commissions_report_on_pharmacy_benefit_manager.pdf
